Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, H. R.
Right arrow Articles by Hedley-Whyte, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, H. R., Jr
Right arrow Articles by Hedley-Whyte, E. T.
NEUROLOGY 1983;33:1479
© 1983 American Academy of Neurology

Idiopathic hemochromatosis (IHC)

Dementia and ataxia as presenting signs

H. Royden Jones, Jr, MD and E. Tessa Hedley-Whyte, MD

Department of Neurology (Dr. Jones), Lahey Clinic Medical Center, Burlington, MA, the C. S. Kubik Laboratory of Neuropathology and the Department of Pathology (Dr. Hedley-Whyte), Massachusetts General Hospital, Boston, MA, and Harvard Medical School (Drs. Jones and Hedley-Whyte), Boston, MA.

Idiopathic hemochromatosis (IHC) is a genetically determined impairment in control of iron absorption that results in excessive parenchymal iron deposition, particularly in the liver. Of patients with IHC, 50% have little or no chemical evidence of liver dysfunction. Cirrhosis may be clinically occult, but still cause a syndrome of chronic hepatocerebral degeneration. Two patients are reported with IHC and a syndrome of ataxia, rigidity, myoclonic jerks, and dementia. Other associated symptoms may include diminished libido, decreased hearing, peripheral neuropathy, and large joint disease. Because symptoms of IHC can be reversed by phlebotomy, appropriate laboratory studies should be considered to exclude IHC in any patient with unexplained dementia, encephalopathy, and gait ataxia.

Address correspondence and reprint requests to Dr. Jones, Department of Neurology, Lahey Clinic Medical Center, 41 Mall Road, Box 541, Burlington, MA 01805.

Presented in part at the thirty-fourth annual meeting of the American Academy of Neurology, Washington, DC, April 1982

Accepted for publication March 7, 1983.




This article has been cited by other articles:


Home page
NeurologyHome page
H. Miyajima, S. Kono, Y. Takahashi, M. Sugimoto, M. Sakamoto, and N. Sakai
Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation
Neurology, December 26, 2001; 57(12): 2205 - 2210.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Ikeda
Iron overload without the C282Y mutation in patients with epilepsy
J. Neurol. Neurosurg. Psychiatry, April 1, 2001; 70(4): 551 - 553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.